Phio Pharmaceuticals Corp. current report, 27 June 2012

Business Context and Reporting Period

This Form 8-K was filed by RXi Pharmaceuticals Corporation (referred to in the metadata as Phio Pharmaceuticals Corp.) on June 27, 2012. The report details the entry into two material definitive agreements regarding the relocation of the company's operational facilities in Massachusetts.

Key Financial Metrics and Obligations

The filing discloses specific lease obligations but does not provide broader financial metrics such as revenue, profit, cash flow, or total debt levels.

  • Office Lease: Base rent of $37,625 per annum for approximately 2,150 square feet in Westborough, MA. Term runs from June 27, 2012, through April 30, 2014.
  • Laboratory Sublease: Base rent of $25,200 per annum for laboratory and office space in Worcester, MA. Term commences October 1, 2012, for one year.
  • Expense Structure: The company is not required to pay taxes or operating expenses under either agreement.

Material Changes

The primary material change is the consolidation and relocation of the company's facilities:

  • Office Relocation: The company moved from Worcester to Westborough on or about June 29, 2012.
  • Laboratory Relocation: The company plans to move its laboratory operations to a new subleased space in Worcester on or about October 1, 2012.

Outlook, Risks, and Management Commentary

Management commentary is limited to the operational details of the leases. Key terms include:

  • Renewal Options: The Office Lease includes an option to renew for one two-year term at 95% of the fair market rental rate, subject to six months' prior notice.
  • Extension Terms: The Laboratory Sublease allows for month-to-month extensions with a 60-day termination notice. Rent increases by 3.5% annually during any option term.
  • Risks: The filing does not explicitly list risks, contingencies, or unusual items beyond the standard obligations of the lease agreements.

Investor Verification Checklist

  • Verify the total annual fixed cost increase of $62,825 ($37,625 + $25,200) against the company's current cash reserves.
  • Confirm the operational readiness of the new Westborough office and Worcester laboratory by the stated move-in dates.
  • Review the "fair market rental rate" definition in the Office Lease to assess potential future cost exposure upon renewal.
  • Check subsequent filings for any updates on the company's liquidity status given the new fixed obligations.